Given the use of camptothecin analogues in cancer therapy32 and the wide therapeutic application of glucocorticoids, the identification of camptothecin as a GR inhibitor raises the question of whether camptothecin and it analogues diminish the anti-inflammatory effects of glucocorticoids in chemotherapy patients. Here, NR3C1 is linked to cancer.